Search clinical trials for: OSI-906
Total 427 results
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-OSI-906United States
-
National Cancer Institute (NCI)CompletedChondrosarcoma | Gastrointestinal Stromal Tumor | Paraganglioma | Carney ComplexUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
University of OxfordAstellas Pharma Inc; European Organisation for Research and Treatment of Cancer... and other collaboratorsCompletedRefractory Ewing Sarcoma | Relapsed Ewing SarcomaUnited Kingdom, Germany, Netherlands, Italy, France
-
University of Colorado, DenverTerminated
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Astellas Pharma IncCompletedAdrenocortical CarcinomaUnited States, France, Netherlands, Italy, Canada, Germany, Australia, Poland, United Kingdom
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
SCRI Development Innovations, LLCNovartis Pharmaceuticals; OSI PharmaceuticalsCompletedMetastatic Colorectal CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Cell Lung CarcinomaUnited States, Singapore
-
Emory UniversityOSI PharmaceuticalsTerminatedLiver CancerUnited States
-
Dana-Farber Cancer InstituteWithdrawnPancreatic Cancer, MetastaticUnited States
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsWithdrawn
-
Emory UniversityOSI PharmaceuticalsWithdrawnNeoplasms | Cancer | TumorsUnited States
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
TakedaWithdrawnHealthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
University of Texas Southwestern Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingRole of Sex Hormones Along the Neuromechanical AxisUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)WithdrawnSquamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVA Squamous Cell Carcinoma of the...United States
-
Ji XunmingUnknown
-
Nova Scotia Health AuthorityMount Saint Vincent UniversityCompletedTrauma, Psychological | Military Family | Veterans FamilyCanada
-
906 CMVI HoldingsCitruslabsActive, not recruitingLibido | Gastrointestinal Issues | IntimacyUnited States
-
CochlearStatistiska KonsultgruppenCompleted
-
Lawson Health Research InstituteCompletedUrinary Bladder, Neurogenic
-
Azienda Ospedaliero-Universitaria di ParmaCompletedPerioperative/Postoperative Complications | Vascular Access ComplicationItaly
-
Nova Scotia Health AuthorityCompletedPhysical DisabilityCanada
-
Bausch & Lomb IncorporatedRecruiting
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
OSI PharmaceuticalsCompletedLocally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line TherapyUnited States
-
OSI PharmaceuticalsCompletedGastric Adenocarcinoma | Gastroesophageal AdenocarcinomaUnited States, United Kingdom, Belgium
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingCataract | VitrectomyFrance
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom
-
Astellas Pharma IncOSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
OSI PharmaceuticalsCompletedLocally Advanced or Metastatic Adenoca of the Biliary TractUnited States, Belgium, Germany, Poland, Romania, Switzerland
-
Ziv HospitalUnknown
-
Boston Scientific CorporationCompletedWalled Off Pancreatic NecrosisUnited States
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
Peking University People's HospitalCompletedCarpal Tunnel SyndromeChina
-
Millennium Pharmaceuticals, Inc.Completed